Immunocore

28.89
-0.48 (-1.63%)
At close: Mar 03, 2025, 3:59 PM
28.88
-0.02%
After-hours: Mar 03, 2025, 04:00 PM EST

Immunocore Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -28.87 -60.41 -52.32 -8.17 -13.56 -8.56 -12.91
PEG Ratio 2.97 -2.36 0.74 -0.25 0.35 -0.19 n/a
PS Ratio 4.75 13.39 15.01 40.53 33.37 34.65 39.09
PB Ratio 4.09 9.06 7.74 6.27 18.16 60.22 16.34
P/FCF Ratio 70.60 -1.34K -64.45 -8.22 -15.79 -8.42 -45.86
P/OCF Ratio 56.59 1.14K -68.98 -8.28 -16.59 -8.77 -55.62
OCF/S Ratio 0.08 0.01 -0.22 -4.89 -2.01 -3.95 -0.7
Debt / Equity Ratio 0.12 0.23 0.25 0.37 1.15 4.02 0.33
Quick Ratio 4.36 3.77 4.70 4.60 3.17 2.05 3.60
Current Ratio 4.38 3.80 4.72 4.29 2.78 1.47 3.45
Asset Turnover 0.31 0.42 0.33 0.09 0.15 0.14 0.12
Interest Coverage -3.74 -11.57 -5.15 -23.25 -27.72 -31.17 -110.99
Return on Equity (ROE) -0.14 -0.15 -0.15 -0.77 -1.34 -7.04 -1.27
Return on Assets (ROA) -0.05 -0.09 -0.09 -0.44 -0.38 -0.56 -0.37
Return on Capital (ROIC) -0.09 -0.13 -0.11 -0.56 -0.61 -1.17 -0.64
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 99.12% 99.58% 99.68% -176.12% -148.42% -289.54% 100.00%
Net Profit Margin -16.47% -22.17% -28.68% -495.94% -246.04% -404.89% -302.82%
Pretax Profit Margin -17.07% -24.41% -30.71% -531.4% -290.1% -491.6% -372.78%
Operating Profit Margin -22.71% -23.91% -27.56% -509.66% -286.22% -460.95% -395.09%
FCF Margin 6.73% -1% -23.28% -493.05% -211.36% -411.59% -85.24%
EBITDA Margin -22.71% -20.71% -26.68% -628.64% -340.66% -440.92% -366.74%